Even if those "Nellies" lose their nerve and add to the selling pressure, it sure will be a good opportunity to top up our holdings at lower prices.IMHO, it's all going to plan and all good for the long term.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
